Cargando…
Glycosylation Profiling of the Neoplastic Biomarker Alpha Fetoprotein through Intact Mass Protein Analysis
[Image: see text] Elevated serum alpha-fetoprotein (AFP) can be observed in liver cirrhosis and hepatocellular carcinoma (HCC). The glycosylation patterns of AFP have been shown to differentiate these conditions, with AFP glycoforms with core fucosylation (AFP-L3) serving as a malignancy risk predic...
Autores principales: | Dunbar, Carmen, Kushnir, Mark M., Yang, Yifei K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830635/ https://www.ncbi.nlm.nih.gov/pubmed/36541409 http://dx.doi.org/10.1021/acs.jproteome.2c00656 |
Ejemplares similares
-
Correction
to Glycosylation Profiling of Neoplastic
Biomarker Alpha Fetoprotein through Intact Mass Protein Analysis
por: Dunbar, Carmen, et al.
Publicado: (2023) -
Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein
por: Chen, Chen-Chun, et al.
Publicado: (2023) -
Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma
por: He, Liang, et al.
Publicado: (2016) -
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
por: Zhang, Zhiguo, et al.
Publicado: (2015) -
Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)